Drug or technology
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 10, 2026 · JOURNAL ARTICLE
Biophysical Reviews
A narrative review synthesizing preclinical mechanistic work and emerging nanoplatform designs, not reporting original clinical or trial data, and explicitly stating that clinical translation remains challenged and further studies are required.
SEP 4, 2026 · JOURNAL ARTICLE
Advanced Functional Materials
This is an early-stage preclinical study demonstrating proof-of-concept for a novel theranostic nanoparticle in mouse models of TNBC, with no human data, no clinical outcomes, and no comparison to standard surgical or immunotherapeutic approaches.
AUG 18, 2026 · JOURNAL ARTICLE
Acs Applied Bio Materials
Early-stage proof-of-concept study demonstrating a novel nanomaterial's feasibility for tumor imaging in vivo, without comparison to a standard imaging agent or clinical validation.
AUG 12, 2026 · JOURNAL ARTICLE
Pharmaceuticals
A narrative review summarizing preclinical and theoretical potential of gold nanoparticles in prostate cancer, without presenting original experimental data, clinical trials, or quantified outcomes.
AUG 11, 2026 · JOURNAL ARTICLE
Nanotoxicology
This is a mechanistic, in vitro comparative study of nanoparticle toxicity across cell types and conditions, offering structure–activity insights but lacking efficacy data, clinical endpoints, or in vivo validation necessary to guide therapeutic development.